Experiment 990474
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Catharanthus roseus (APOCYNACEAE) |
| Citation | GRALLA,RJ: RAPHAEL,BG: GOLBEY,RB: YOUNG,CW:. (1979). PHASE II EVALUATION OF VINDESINE IN PATIENTS WITH NON-SMALL CELL CARCINOMA OF THE LUNG.. 63() |
| Amount utilized | |
| Compound isolated | |
| Disease | A PHASE II CLINICAL TRIAL INVOLVING 52 SUBJECTS WITH NON-SMALL CELL CARCINOMA OF THE LUNG PARTIAL REMISSIONS IN 10/46 ADEQUATELY TREATED PATIENTS:OVERALL RESPONSE RATE WAS 22% DURATION OF PARTIAL REMISSIONS WAS 2-9 MONTHS MEDIAN NUMBER OF DOSES GIVEN WAS 6 PER PATIENT(RANGE,3-33 DOSES) LEUKOPENIA WAS THE MOST COMMOM MANIFESTATION OF MYELOSUPPRESSION.PERIPHERAL NEUROPATHY WAS THE MOST PROMINENT TOXIC EFFECT |
| Dose amount | 3.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |